Table 1.
Antimicrobial susceptibility pattern of various bacterial isolates from diabetic foot ulcer
| Antibiotics | Escherichia coli (n=38), n (%) | Klebsiella pneumoniae (n=15), n (%) | Klebsiella oxytoca (n=6), n (%) | Proteus mirabilis (n=18), n (%) | Proteus vulgaris (n=5), n (%) | Citrobacter spp. (n=7), n (%) | Pseudomonas spp. (n=15), n (%) | Acinetobacter spp. (n=5), n (%) |
|---|---|---|---|---|---|---|---|---|
| Cefepime | 18 (47) | 10 (67) | 1 (17) | 4 (22) | 3 (60) | 3 (43) | - | - |
| Ceftazidime | 21 (55) | 13 (87) | 3 (50) | 4 (22) | 3 (60) | 3 (43) | 5 (33) | 3 (60) |
| Ceftriaxone | 23 (60) | 15 (100) | 4 (67) | 4 (22) | 3 (60) | 4 (57) | 5 (33) | 3 (60) |
| Cefoxitin | 20 (53) | 8 (53) | 3 (50) | 3 (17) | 4 (80) | 5 (71) | - | - |
| Amoxyclav | 24 (63) | 11 (73) | 4 (67) | 3 (17) | 2 (40) | 5 (71) | - | - |
| Ceftazidime/clavulanic acid | 16 (42) | 9 (60) | 2 (33) | 3 (17) | 1 (20) | 3 (43) | - | - |
| Tobramycin | - | - | - | - | - | - | 5 (33) | 3 (60) |
| Ciprofloxacin | 17 (45) | 9 (60) | 5 (83) | 6 (33) | 3 (60) | 5 (71) | 8 (53) | 5 (100) |
| Piperacillin/tazobactam | 16 (42) | 7 (47) | 2 (33) | 3 (17) | 2 (40) | 4 (57) | - | - |
| Amikacin | 15 (39) | 12 (80) | 2 (33) | 3 | 1 (20) | 3 (43) | 7 (46) | 2 (40) |
| Imipenem | 5 (13) | 3 (20) | 1 (17) | 1 (5) | 1 (20) | 1 (14) | 3 (20) | 2 (40) |
| Aztreonam | - | - | - | - | - | - | 5 (33) | 3 (60) |
| Colistin | - | - | - | - | - | - | 2 (13) | 0 |
| Polymyxin | - | - | - | - | - | - | 1 (7) | 0 |